Hologic logo, dark blue
Hologic logo, dark blue

Respiratory Testing Solution

A fully-automated approach to respiratory testing.

Get in Touch
Multiple assay boxes in lab background

Simplify & Scale Your Testing Capacity

Readiness for the respiratory viral season is a priority for every lab. As COVID-19 shifts from pandemic to endemic, accurate and timely detection and differentiation of viruses with flu-like symptoms will be crucial to guide patient care and assist infection control.

To help you simplify and scale testing capacity, the Hologic Molecular Scalable Solutions respiratory portfolio now offers new multiplex assays, including for SARS-CoV-2, for both on-demand and high-throughput testing. The two new assays, covering Flu A, Flu B, RSV and SARS-CoV-2, enable high-throughput and on-demand testing of the most common respiratory viruses, helping you diagnose and deliver results sooner. From a single patient rapid result on the Novodiag® system, through to high volume testing at scale on the Panther® Fusion System.1,2

Resilience to Cope With Seasonal Surges

We have built up our expertise in developing high-performing assays in the response to the unparalleled demands of SARS-CoV-2. 

We help labs build first-class diagnostic capability and capacity, to meet seasonal demands and emerging global threats.

When demand peaks, you need a solution that you can trust and that deliver results.

Flexibility to do More With Less

We offer a fully automated, modular approach to syndromic respiratory testing, enabling you to target the right patient with the right test.

Our respiratory solution allows you to act quickly and at scale, with greater flexibility.

Both high throughput and on-demand testing is available for the most common respiratory infections.

Boosting Workflow Efficiency & Clinical Insight

We continually invest in research and development to improve our portfolio to help meet your needs.

Our two latest assays combine four targets in one high-performance assay, Flu A, Flu B, RSV and SARS-CoV-2. 1,2

These assays let you test a single specimen from a patient who may have overlapping symptoms.1,2

Personalised Patient Testing

Personalised patient testing enables accurate and timely diagnosis.

True random access, STAT applications and on-demand testing offer workflow efficiency, allowing samples to be continuously loaded without the need to batch to perform multiple test orders.

This help you to prioritise urgent patients without impacting wider testing workflow.

Combining High Assay Performance with Automation

One sample and multiple testing capability depending on clinical needs gives you a modular approach for syndromic, respiratory testing.

3 Tiers

of automation with the Novodiag, Panther and Panther Fusion providing scalable support.

5 Assays

focused on SARS-CoV-2, from on-demand to high-volume screening and differentiating SARS-CoV-2.

13 Viruses

our family of assays targets multiple respiratory viruses.

2 New

assays covering Flu A, Flu B, RSV and SARS-CoV-2.

Explore the Respiratory Testing Solution

Image of Assay box on white background

Panther Fusion® SARS-CoV-2/Flu A/B/RSV Assay

A fully-automated approach to respiratory testing of SARS-CoV-2, respiratory syncytial virus (RSV), influenza A (Flu A) and influenza B (Flu B) in one single assay, differentiating respiratory infections with overlapping symptoms.1

Image of Assay box on white background

Aptima® SARS-CoV-2 Assay

Fully-automated, high-throughput assay for the detection of SARS-CoV-2.3 Meet the urgent need for high-throughput and fully-automated testing, delivering more than 1000 test results in 24 hours. Number of actual test results per day may vary based on individual lab practices and workflows.4

Image of Assay box on white background

Aptima® SARS-CoV-2/Flu Assay

Fully automated, high-throughput assays for the detection of SARS-CoV-2, influenza A (Flu A) and influenza B (Flu B) in one single assay, differentiating respiratory infections with overlapping symptoms.5

Image of Assay box on white background

Panther Fusion® Flu A/B/RSV Assay

A fully-automated approach to respiratory testing of respiratory syncytial virus (RSV), influenza A (Flu A) and influenza B (Flu B) in one single assay, differentiating respiratory infections with overlapping symptoms.6

Image of Assay box on white background

Panther Fusion® AdV/hMPV/RV Assay

A fully-automated approach to respiratory testing of adenovirus (AdV), human metapneumovirus (hMPV) and rhinovirus (RV) in one single assay, differentiating respiratory infections with overlapping symptoms.7

Image of Assay box on white background

Panther Fusion® Paraflu Assay

A fully automated approach to respiratory testing of parainfluenza 1, 2, 3 and 4 in one single assay. A multiplex, real-time PCR (RT-PCR) in vitro diagnostic test.8

Image of Assay box on white background

Panther Fusion® Bordetella Assay

A fully-automated approach to respiratory testing of Bordetella pertussis and Bordetella parapertussis in one single assay.9

Image of Panther® Scalable Solution on white background

Panther® Scalable Solution

The Hologic high-throughput solution allows you to expand your testing menu while adding on flexibility, capacity and walkaway time. The Panther® System is the foundation of Panther Scalable Solutions. It lets you customise your testing by choosing from a broad assay menu and instrument add-ons, allowing an economical and scalable path to your growth.

Image of Assay on white background

Novodiag® RESP-4 Assay

A cartridge-based molecular test for the detection and differentiation of SARS-CoV-2, Flu A, Flu B and RSV in one single assay.2 The test uses nasopharyngeal swab samples from patients.

Image of Assay on white background

Novodiag® COVID-19 Assay

A cartridge-based RT-PCR test for qualitative detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).10 The test uses nasopharyngeal swab samples from patients.

Image of system on white background

Novodiag® System

The small, quiet, stackable, fully-automated system combines easy-to-use functionality with PCR performance, to bring clinical confidence closer to patients. Has the flexibility to deliver fast individual results.11

Load more

Get Support

All Other Requests

Insights

Visit the Hologic Innovation Exchange

Increase Efficiency & Reduce Costs

Accurate and timely diagnosis of the cause of respiratory tract infections has a number of benefits for patients and their communities, including:

  • Reduces potential for further development of antimicrobial resistance due to antibiotics12
  • Improves patient care and helps decrease costs12,13
  • Provides valued information to public health authorities regarding which viruses are circulating in the community14
  • Assists infection control personnel to provide appropriate measures to minimise nosocomial spread15
Lab technician with multiple assay boxes in lab background
    References
    1. Panther Fusion SARS-CoV-2/Flu A/B/RSV assay [package insert]. AW-25328-001 Rev. 001. San Diego, CA: Hologic, Inc.; 2022
    2. Novodiag® RESP-4 Instructions for Use V1-0 – May 2022, Espoo, FINLAND; Mobidiag Ltd. 2022
    3. Aptima SARS-CoV-2 assay [package insert]. AW-22752-001 Rev. 005. San Diego, CA: Hologic, Inc.; 2023
    4. Vandenberg O, Martiny D, Rochas O, van Belkum A, Kozlakidis Z. Considerations for diagnostic COVID-19 tests. Nat Rev Microbiol. 2021 Mar;19(3):171-183. doi: 10.1038/s41579-020-00461-z. Epub 2020 Oct 14. PMID: 33057203; PMCID: PMC7556561.
    5. Aptima SARS-CoV-2/Flu assay [package insert]. AW-22365-001 Rev. 004. San Diego, CA: Hologic, Inc.; 2023.
    6. Panther Fusion Flu A/B/RSV assay [package insert]. AW-23081 Rev. 001. San Diego, CA: Hologic, Inc.; 2022. 
    7. Panther Fusion AdV/hMPV/RV assay [package insert]. AW-29005 Rev. 001. San Diego, CA: Hologic, Inc.; 2023. 
    8. Panther Fusion Paraflu assay [package insert]. AW-23708-001 Rev 001. San Diego, CA: Hologic, Inc.; 2023.
    9. Panther Fusion Bordetella assay [package insert]. AW-18637-001, Rev. 001. San Diego, CA: Hologic, Inc.; 2018
    10. Novodiag® COVID-19 Instructions for Use V10-0 – May 2022, Espoo, FINLAND; Mobidiag Ltd. 2022
    11. Novodiag® System Instructions for Use V7-0 – May 2022, Espoo, FINLAND; Mobidiag Ltd. 2022
    12. Pinsky BA, Hayden RT. Cost-Effective Respiratory Virus Testing. J Clin Microbiol. 2019 Aug 26;57(9):e00373-19. doi: 10.1128/JCM.00373-19. PMID: 31142607; PMCID: PMC6711893.
    13. https://www.health.vic. gov.au/health-advisories/testing-for-respiratory-pathogens Accessed August, 2022.
    14. WHO-2019-nCoV-Surveillance-Guidance-2022.1-eng.pdf https://www.who.int/publications/i/item/WHO-2019-nCoV-SurveillanceGuidance-2022.2 Accessed October, 2022.
    15. Lim RHF, Htun HL, Li AL, Guo H, Kyaw WM, Hein AA, Ang B, Chow A. Fending off Delta - Hospital measures to reduce nosocomial transmission of COVID-19. Int J Infect Dis. 2022 Apr;117:139-145. doi: 10.1016/j.ijid.2022.01.069. Epub 2022 Feb 4. PMID: 35124240; PMCID: PMC8813202.
     

    Related Portfolios & Solutions

    Lab technician in white coat carrying test tubes
    Portfolio

    Molecular Scalable Solution

    A scalable portfolio combining a broad, high performing assay menu with high throughput automation. Designed to flexibly scale to meet your needs, from a single patient rapid result to population level screening.

    Multiple Thinprep vials on rack
    Portfolio

    Cervical Health

    We offer a comprehensive cervical cancer screening portfolio, from sample collection to diagnosis. Our leading technologies provide effective, robust and proven end-to-end solutions that meet the needs of all commonly used national cervical cancer screening programs.

    Solution

    High-Throughput Testing

    Solution

    On-Demand Testing

    Solution

    HPV

    Solution

    Vaginal health

    Solution

    STI

    Solution

    Virology

    Solution

    Transplant

    Solution

    Hospital Acquired Infections

    Solution

    Gastrointestinal

    Solution

    Antimicrobial Resistance

    Solution

    Collection Devices

    Solution

    Lab Developed Tests

    2797

    Hologic BVBA Da Vincilaan 5 1930 Zaventem Belgium

    Notified Body number wherever applicable

    EC Rep details wherever applicable